Is alectinib-induced elevation of creatine phosphokinase a predictive factor for response? Report of two cases and review of the literature

Shalata, W; Massalha, I; Agbarya, A

Agbarya, A (corresponding author), Technion, Bruce Fac Med, Oncol Dept, Bnai Zion Med Ctr, Haifa, Israel.

ANTI-CANCER DRUGS, 2021; 32 (4): 456

Abstract

We aim to describe two cases of creatine phosphokinase (CPK) and liver enzymes elevation occurring as adverse effects of alectinib (Alecensa) treatmen......

Full Text Link